Applications of Deep Learning for Drug Discovery Systems with BigData

Abstract

The adoption of “artificial intelligence (AI) in drug discovery”, where AI is used in the process of pharmaceutical research and development, is progressing. By using the ability to process large amounts of data, which is a characteristic of AI, and achieving advanced data analysis and inference, there are benefits such as shortening development time, reducing costs, and reducing the workload of researchers. There are various problems in drug development, but the following two issues are particularly problematic: (1) the yearly increases in development time and cost of drugs and (2) the difficulty in finding highly accurate target genes. Therefore, screening and simulation using AI are expected. Researchers have high demands for data collection and the utilization of infrastructure for AI analysis. In the field of drug discovery, for example, interest in data use increases with the amount of chemical or biological data available. The application of AI in drug discovery is becoming more active due to improvement in computer processing power and the development and spread of machine-learning frameworks, including deep learning. To evaluate performance, various statistical indices have been introduced. However, the factors affected in performance have not been revealed completely. In this study, we summarized and reviewed the applications of deep learning for drug discovery with BigData.

Explainable Artificial Intelligence for Drug Discovery and Development: A Comprehensive Survey

“…Looking into methods for dynamically changing XAI explanations as models change and new data streams in. This study might produce explanations that continue to be correct, pertinent, and in line with how drug development is evolving [87]. The insights provided to researchers and clinicians can maintain their interpretability and reliability by using adaptable XAI frameworks that automatically update explanations in response to model updates or changes in data distribution [88].…”

Halogenated Antimicrobial Agents to Combat Drug-Resistant Pathogens

“…Many properties, conditions, and actions of halogens may be responsible for the enhanced antimicrobial potencies of halogenated antimicrobial agents, but regardless of the number of halogenated agents available, studies are limited. Interestingly, several machine learning and artificial intelligence-based software packages, such as DeepChem, DeltaVina, Chemputer, Open Drug Discovery Toolkit (ODDT), AMPlify SCScore, and DeepNeuralNet-QSAR (Matsuzaka and Yashiro, 2022;Peña-Guerrero et al, 2021;Staszak et al, 2022), are now used for lead optimization and predicting these properties. Application of these…”

Reinventing Therapeutic Proteins: Optimizing Investments and Meeting Humanitarian Needs

“…Under development are many new AI tools for screening active compounds in the search for hit compounds and enhancing the efficiency of the development process. 68 • AtomNet is a convolutional neural network-based tool that applies the concepts of feature locality and hierarchical composition extracted through protein sequence, structure, and function to model bioactivity and chemical interactions of potential drug targets. 69 AtomNet's parent AtomWise has recently enabled the rapid discovery of drugs against 27 disease targets.…”